Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Song

Showing results (571-580 of 612) with videos related to

Pageof 62
Sort By:
Medicine|November 15, 2019
Longitudinal follow-up study of the retrobulbar and intrarenal hemodynamics in patients with T2DMHe Tai, Xiao-Lin Jiang, Jin-Song Kuang, et al.
Journal of Geriatric Cardiology : JGC|November 13, 2018
Repeated measurement of growth-differentiation factor-15 in Chinese Han patients with post-myocardial infarction chronic heart failureJi-Xuan Liu, Yan-Ping Li, Bo-Han Liu, et al.
Signal Transduction and Targeted Therapy|February 28, 2022
Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesisXiaobo Zheng, Jinen Song, Chune Yu, et al.
Science Advances|March 5, 2025
An antidepressant mechanism underlying the allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneuronsJilin Zhang, Jinjin Duan, Wei Li, et al.
The Journal of Clinical Investigation|September 5, 2018
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesisDongxue Su, Shuai Ma, Lin Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trialKatherine L Pogue-Geile, Nan Song, Jong-Hyeon Jeong, et al.
The New England Journal of Medicine|January 21, 2016
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerPiero Dalerba, Debashis Sahoo, Soonmyung Paik, et al.
Nature Communications|August 3, 2023
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II studyDongliang Bian, Liangdong Sun, Junjie Hu, et al.
The Pharmacogenomics Journal|April 6, 2018
Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS)Ji-Eun Kim, Jaesung Choi, JooYong Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood CancerNa Qin, Zhaoming Wang, Qi Liu, et al.
Pageof 62

Showing results (571-580 of 612) with videos related to

Sort By:
Pageof 62
Medicine|November 15, 2019
Longitudinal follow-up study of the retrobulbar and intrarenal hemodynamics in patients with T2DMHe Tai, Xiao-Lin Jiang, Jin-Song Kuang, et al.
Journal of Geriatric Cardiology : JGC|November 13, 2018
Repeated measurement of growth-differentiation factor-15 in Chinese Han patients with post-myocardial infarction chronic heart failureJi-Xuan Liu, Yan-Ping Li, Bo-Han Liu, et al.
Signal Transduction and Targeted Therapy|February 28, 2022
Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesisXiaobo Zheng, Jinen Song, Chune Yu, et al.
Science Advances|March 5, 2025
An antidepressant mechanism underlying the allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneuronsJilin Zhang, Jinjin Duan, Wei Li, et al.
The Journal of Clinical Investigation|September 5, 2018
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesisDongxue Su, Shuai Ma, Lin Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trialKatherine L Pogue-Geile, Nan Song, Jong-Hyeon Jeong, et al.
The New England Journal of Medicine|January 21, 2016
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerPiero Dalerba, Debashis Sahoo, Soonmyung Paik, et al.
Nature Communications|August 3, 2023
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II studyDongliang Bian, Liangdong Sun, Junjie Hu, et al.
The Pharmacogenomics Journal|April 6, 2018
Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS)Ji-Eun Kim, Jaesung Choi, JooYong Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood CancerNa Qin, Zhaoming Wang, Qi Liu, et al.
Pageof 62